In this model, PGE2 is meant to subsequently activate PPARβ/δ indirectly via cPLA2α, thereby triggering a positive feedback loop controlling cholangiocarcinoma cell proliferation. The gene discussed is PPARD; the disease is cholangiocarcinoma.